Mark Avagliano serves as Executive at G1 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mark Avagliano has executed 16 insider transactions totaling $73.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 18, 2024 involved selling 236,610 shares valued at $0.
Mark Avagliano currently holds 26,035 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Avagliano has been a net seller of GTHX stock. They have purchased $0 and sold $73.6K worth of shares.
Mark Avagliano's most recent insider trade was on Sep 18, 2024, when they sold 236,610 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 18, 2024 | GTHX | $0 | Tender | 26,035 | $N/A | Discretionary |
| Jul 5, 2024 | GTHX | $6.6K | Sale | 2,638 | $2.51 | Discretionary |
| Jul 1, 2024 | GTHX | $0 | Award | 35,000 | $N/A | Discretionary |
| May 13, 2024 | GTHX | $39.0K | Sale | 8,151 | $4.79 | Discretionary |
| Mar 20, 2024 | GTHX | $0 | Award | 100,000 | $N/A | Discretionary |
| Jan 4, 2024 | GTHX | $2.1K | Sale | 721 | $2.94 | Discretionary |
| Jan 3, 2024 | GTHX | $8.1K | Sale | 2,602 | $3.12 | Discretionary |
| Jan 3, 2024 | GTHX | $2.4K | Sale | 758 | $3.12 | Discretionary |
| Jan 3, 2024 | GTHX | $0 | Award | 44,760 | $N/A | Discretionary |
| May 10, 2023 | GTHX | $0 | Award | 35,000 | $N/A | Discretionary |
| Jan 3, 2023 | GTHX | $0 | Award | 20,600 | $N/A | Discretionary |
| Jan 5, 2022 | GTHX | $15.3K | Sale | 1,445 | $10.61 | Discretionary |
| Jan 3, 2022 | GTHX | $0 | Award | 12,000 | $N/A | Discretionary |
| Jan 4, 2021 | GTHX | $0 | Award | 11,000 | $N/A | Discretionary |